YORBA LINDA, CALIF. (PRWEB) MARCH 17, 2022 Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, today announced Cannabis Sciences 2022, hosted on March 23rd with an exceptional lineup of prominent experts spanning sessions including, Medical Cannabis – Therapeutic Updates, The Evolving Regulatory Landscape, Analytical Testing and Automation, Advancements in Cultivation and Extraction Methods, and Hot Topics. Entering its 5th …
KINGSVILLE, ON, March 17, 2022 /CNW/ – Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (“Greenway Greenhouse” or the “Company”) is proud to announce their support of the Southwestern Ontario cannabis and agriculture industries through their platinum sponsorship of the inaugural CannabisWiki Conference and Expo in London, Ontario on June 15 and 16, 2022. The first annual CannabisWiki Conference and Expo is hosted by, and presented in partnership with, the …
Washington, DC: The U.S. Department of Transportation has proposed changes to existing federal drug testing guidelines that would allow for the use of oral fluid testing as an alternative to urinalysis for those working in the transportation industry. The agency proposed the rule change in the February 28, 2022 edition of the Federal Register, opining, “This will give employers a choice that will help combat …
San Francisco, CA: Current cannabis use is associated with lower resting heart rate, according to data published in The American Journal of Medicine. A team of researchers from Switzerland and the United States assessed the relationship between cannabis exposure and heart rate in a cohort of middle-aged adults. Subjects in the study were participants in the Coronary Artery Risk Development in Young Adults (CARDIA) …
Alberta, Canada: The magnitude of cannabis’ influence on driving performance is far less than that of alcohol, according to a systematic review and meta-analysis published in the journal Addiction. Canadian researchers analyzed data from 57 studies assessing the influence of cannabis and alcohol on driving behavior and crash risk. They acknowledged that cannabis exposure was typically associated with deviation in drivers’ lateral positioning (lane …
New York, NY: The majority of internists in training possess little or no knowledge about the use of cannabis for medicinal purposes, according to survey data published in the journal BMJ Primary Care. A team of investigators with the Icahn School of Medicine at Mount Sinai in New York surveyed a group of internal medicine residents regarding their knowledge about the medical use of …
Milan, Italy: The long-term use of plant-derived cannabis extracts by patients with chronic pain is associated with reduced reliance on prescription opioids, according to data published in the European Review for Medical and Pharmacological Sciences. A team of Italian researchers assessed the use of prescription opioids and other medicines in a cohort of chronic patients in the six months immediately prior to and immediately …
PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced that the Company’s CEO, Dr. Pnina Fishman, will deliver a poster presentation titled “Inhibition of Hepatocellular Carcinoma Growth and Liver Fibrosis by Nanomolar Cannabinoids Concentrations” at the CannX Medical Cannabis Conference …
AUSTIN, Texas–(BUSINESS WIRE)–Texas Original Compassionate Cultivation (TXOG), Texas’ leading medical cannabis provider, today released results from its clinical evaluation of the company’s post-traumatic stress disorder (PTSD) focus group. Focus group participants sampled TXOG’s gummy, lozenge and tincture products at various dosages based on individual prescriptions from their physicians. Following the focus group’s completion, TXOG released survey results in which patients reported quick onset …
HERZLIYA, Israel, March 8, 2022 /PRNewswire/ — Cannabotech, a biomedical company developing oncological products based on cannabis and mushroom extracts, reports cell model study results showing that its “Integrative-Colon” products killed over 90% of colon cancer cells. The Integrative-Colon products are based on a combination of several cannabinoids from the cannabis plant and various mushroom extracts. The study examined the effect of Cannabotech’s …